Latest & greatest articles for hypertension

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hypertension or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hypertension and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hypertension

141. A Case of a “Voiding” Hypertension

A Case of a “Voiding” Hypertension 29270506 2018 11 13 2468-0249 2 5 2017 Sep Kidney international reports Kidney Int Rep A Case of a "Voiding" Hypertension. 973-977 10.1016/j.ekir.2017.02.018 Shahid Kainat K Division of Nephrology, St. Michael's Hospital, Toronto, Ontario, Canada. Streutker Catherine J CJ Department of Laboratory Medicine, St. Michael's Hospital, Toronto, Ontario, Canada. Kim Raymond H RH University Health Network & Mount Sinai Hospital, The Fred A Litwin Family Centre

Kidney international reports2017 Full Text: Link to full Text with Trip Pro

142. Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension

Trial of Decompressive Craniectomy for Traumatic Intracranial Hypertension PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

PedsCCM Evidence-Based Journal Club2017

143. Automated Versus Manual Blood Pressure Monitoring for Hypertension in the Community Setting: Comparative Clinical and Cost-Effectiveness and Guidelines

Automated Versus Manual Blood Pressure Monitoring for Hypertension in the Community Setting: Comparative Clinical and Cost-Effectiveness and Guidelines Automated Versus Manual Blood Pressure Monitoring for Hypertension in the Community Setting: Comparative Clinical and Cost-Effectiveness and Guidelines | CADTH.ca Find the information you need Automated Versus Manual Blood Pressure Monitoring for Hypertension in the Community Setting: Comparative Clinical and Cost-Effectiveness and Guidelines (...) Automated Versus Manual Blood Pressure Monitoring for Hypertension in the Community Setting: Comparative Clinical and Cost-Effectiveness and Guidelines Published on: February 21, 2017 Project Number: RB1065-000 Product Line: Research Type: Devices and Systems Report Type: Summary of Abstracts Result type: Report Question What is the comparative clinical effectiveness of automated versus manual blood pressure monitoring in patients with hypertension or suspected hypertension in the community setting

Canadian Agency for Drugs and Technologies in Health - Rapid Review2017

144. Recommended Standards for Assessing Blood Pressure in Human Research Where Blood Pressure or Hypertension Is a Major Focus

Recommended Standards for Assessing Blood Pressure in Human Research Where Blood Pressure or Hypertension Is a Major Focus 29142989 2018 11 13 2468-0249 2 4 2017 Jul Kidney international reports Kidney Int Rep Recommended Standards for Assessing Blood Pressure in Human Research Where Blood Pressure or Hypertension Is a Major Focus. 733-738 10.1016/j.ekir.2017.02.009 Although inaccurate, nonreproducible blood pressure values can result from nonstandardized assessments, recommended approaches (...) to standardize blood pressure measurement are often not followed in research studies. An expert consensus of national and international health and scientific organizations developed recommended minimum standards for assessing blood pressure in research subjects where: (i) blood pressure or hypertension is a major endpoint, or (ii) blood pressure is likely a major mediator of the research outcome. Minimum research standards are presented for training of observers, technical aspects of assessing blood

Kidney international reports2017 Full Text: Link to full Text with Trip Pro

145. Fractionated Concurrent Exercise throughout the Day Does Not Promote Acute Blood Pressure Benefits in Hypertensive Middle-aged Women

Fractionated Concurrent Exercise throughout the Day Does Not Promote Acute Blood Pressure Benefits in Hypertensive Middle-aged Women 28261583 2018 11 13 2297-055X 4 2017 Frontiers in cardiovascular medicine Front Cardiovasc Med Fractionated Concurrent Exercise throughout the Day Does Not Promote Acute Blood Pressure Benefits in Hypertensive Middle-aged Women. 6 10.3389/fcvm.2017.00006 Hypertension is a chronic disease that affects about 30% of the world's population, and the physical (...) exercise plays an important role on its non-pharmacological treatment. Anywise, the dose - response of physical exercise fractionation throughout the day demands more investigation, allowing new exercise prescription possibilities. Therefore, this study aimed to analyze the acute blood pressure (BP) kinetics after 1 h of exercises and the BP reactivity after different concurrent exercise (CE) sessions and its fractioning of hypertensive middle-aged women. In this way, 11 hypertensive women voluntarily

Frontiers in cardiovascular medicine2017 Full Text: Link to full Text with Trip Pro

147. The XXI International Society of Hypertension in Pregnancy meeting, São Paulo, Brazil – A global health perspective

The XXI International Society of Hypertension in Pregnancy meeting, São Paulo, Brazil – A global health perspective 28491129 2018 11 13 1753-495X 10 1 2017 Mar Obstetric medicine Obstet Med The XXI International Society of Hypertension in Pregnancy meeting, São Paulo, Brazil - A global health perspective. 30-32 10.1177/1753495X16689359 The 21st International Society of Hypertension in Pregnancy (ISSHP) meeting was held in São Paulo, Brazil from 23 to 26 October 2016. The discourse (...) at this Congress brought global maternal health into the foray among basic science and clinical research. In concordance with the United Nations sustainable development goals which warrant an integrated view to health with investments in adolescence and childhood, the research at Congress focussed on a 'life course' approach to maternal health - examining intergenerational effects of maternal obesity and hypertension on the behavioral and physical developments of infants. Bringing in research from the Global

Obstetric medicine2017 Full Text: Link to full Text with Trip Pro

148. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians.

Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians. Description: The American College of Physicians (ACP) and the American Academy of Family Physicians (AAFP) jointly developed this guideline to present the evidence and provide clinical recommendations based on the benefits and harms of higher versus lower blood (...) pressure targets for the treatment of hypertension in adults aged 60 years or older. Methods: This guideline is based on a systematic review of published randomized, controlled trials for primary outcomes and observational studies for harms only (identified through EMBASE, the Cochrane Database of Systematic Reviews, MEDLINE, and ClinicalTrials.gov), from database inception through January 2015. The MEDLINE search was updated through September 2016. Evaluated outcomes included all-cause mortality, morbidity

Annals of Internal Medicine2017

149. Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.

Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015. Importance: Elevated systolic blood (SBP) pressure is a leading global health risk. Quantifying the levels of SBP is important to guide prevention policies and interventions. Objective: To estimate the association between SBP of at least 110 to 115 mm Hg and SBP of 140 mm Hg or higher and the burden of different causes of death and disability by age and sex for 195 countries and territories, 1990

JAMA2017

150. Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature

Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature 28119918 2018 11 13 2297-055X 3 2016 Frontiers in cardiovascular medicine Front Cardiovasc Med Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature. 51 10.3389/fcvm.2016.00051 Despite the high prevalence of hypertension (HTN), only a small proportion of the hypertensive patients will ultimately develop hypertensive crisis. In fact, some patients with hypertensive crisis do not report (...) a history of HTN or previous use of antihypertensive medication. The majority of the patients with hypertensive crisis often report non-specific symptoms, whereas heart-related symptoms (dyspnea, chest pain, arrhythmias, and syncope) are less common. Hypertensive crises can be divided into hypertensive emergencies or hypertensive urgencies according to the presence or absence of acute target organ damage, respectively. This differentiation is an extremely useful classification in clinical practice since

Frontiers in cardiovascular medicine2017 Full Text: Link to full Text with Trip Pro

151. Riociguat for the treatment of pulmonary hypertension

Riociguat for the treatment of pulmonary hypertension Riociguat for the treatment of pulmonary hypertension Riociguat for the treatment of pulmonary hypertension Tapia-López E, Rey-Ares L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A Citation Tapia-López E, Rey-Ares L, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, Ciapponi A, López A. Riociguat for the treatment of pulmonary hypertension. Buenos Aires: Institute for Clinical (...) Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No. 475. 2016 Authors' conclusions Evidence of moderate methodological quality shows that riociguat, when compared with placebo, improves short-term functional capacity in patients with Functional Class II and III pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. No evidence was found assessing mortality or comparing riociguat with other widely used therapeutic alternatives of proven efficacy, safety

Health Technology Assessment (HTA) Database.2017

152. Hypertension: delicate choice of blood pressure target

Hypertension: delicate choice of blood pressure target Prescrire IN ENGLISH - Spotlight ''Hypertension: delicate choice of blood pressure target'', 1 January 2017 {1} {1} {1} | | > > > Hypertension: delicate choice of blood pressure target Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |   |   |   |   |   |   |   |   |  Spotlight Hypertension: delicate choice of blood pressure target Aiming (...) , and the patients involved were not representative of the majority of patients with hypertension: those in the trial were at high risk of a cardiovascular event, often overweight but not diabetic, with no history of stroke or symptomatic cardiac failure. The mortality benefit was obtained at the price of twice the number of severe adverse effects, especially renal. As a result of trying to achieve a systolic pressure of around 120 mm Hg, most patients had to take at least three antihypertensive drugs, thus

Prescrire2017

153. Global burden of hypertension: analysis of worldwide data.

Global burden of hypertension: analysis of worldwide data. BACKGROUND: Reliable information about the prevalence of hypertension in different world regions is essential to the development of national and international health policies for prevention and control of this condition. We aimed to pool data from different regions of the world to estimate the overall prevalence and absolute burden of hypertension in 2000, and to estimate the global burden in 2025. METHODS: We searched the published (...) literature from Jan 1, 1980, to Dec 31, 2002, using MEDLINE, supplemented by a manual search of bibliographies of retrieved articles. We included studies that reported sex-specific and age-specific prevalence of hypertension in representative population samples. All data were obtained independently by two investigators with a standardised protocol and data-collection form. RESULTS: Overall, 26.4% (95% CI 26.0-26.8%) of the adult population in 2000 had hypertension (26.6% of men [26.0-27.2%] and 26.1

Lancet2017

154. Pharmacological Management of Hypertension

Pharmacological Management of Hypertension Pharmacological Management of Hypertension | National Guideline Clearinghouse success fail JUL Aug 12 2017 2018 2019 02 Oct 2017 - 13 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers (...) * Remember Me Don't have an account? The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018 because federal funding through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our . Guideline Synthesis Pharmacological Management of Hypertension Guidelines Being Compared: American College of Physicians (ACP) Pharmacologic treatment of hypertension in adults aged 60 years or older to higher versus

National Guideline Clearinghouse (partial archive)2017

155. Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians

Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline from the American College of Physicians and the American Academy of Family Physicians Pharmacologic Treatment of Hypertension in Adults | Annals of Internal Medicine | American College of Physicians '); } Sign in below to access your subscription for full content INDIVIDUAL SIGN IN | You will be directed to acponline.org to register and create (...) your Annals account INSTITUTIONAL SIGN IN | | Subscribe to Annals of Internal Medicine . You will be directed to acponline.org to complete your purchase. Search Clinical Guidelines | 21 March 2017 Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline From the American College of Physicians and the American Academy of Family Physicians Free Amir Qaseem, MD, PhD, MHA; Timothy J. Wilt, MD, MPH; Robert Rich

American College of Physicians2017

156. Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period

Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period - ACOG Menu ▼ Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period Page Navigation ▼ Number 692, April 2017 (Replaces Committee Opinion No. 623, February 2015) Committee on Obstetric Practice This Committee Opinion was developed by the American College (...) of Obstetricians and Gynecologists’ Committee on Obstetric Practice in collaboration with committee members Yasser Y. El-Sayed, MD, and Ann E. Borders, MD, MSc, MPH. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Emergent Therapy for Acute-Onset, Severe Hypertension During Pregnancy and the Postpartum Period ABSTRACT: Acute-onset

American College of Obstetricians and Gynecologists2017

158. Hypertension in patients undergoing carotid endarterectomy

Hypertension in patients undergoing carotid endarterectomy Hypertension in patients undergoing carotid endarterectomy Hypertension in patients undergoing carotid endarterectomy Mitchell MD, Malloy C, Wang GJ, Mull, N. Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mitchell MD, Malloy C, Wang GJ, Mull, N.. Hypertension in patients (...) undergoing carotid endarterectomy. Philadelphia: Center for Evidence-based Practice (CEP). 2017 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Carotid Artery Diseases; Endarterectomy, Carotid; Humans; Hypertension Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence Center for Evidence-based Practice, University of Pennsylvania Health System, 3535 Market St. Suite 50, Philadelphia

Health Technology Assessment (HTA) Database.2017

159. Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease

Hypertension management and renin-angiotensin-aldosterone system blockade in patients with diabetes, nephropathy and/or chronic kidney disease

Association of British Clinical Diabetologists2017

160. Randomised controlled trial: Intensive treatment of hypertension to a SBP <120?mm?Hg in patients aged 75 and over reduces mortality and cardiovascular events

Randomised controlled trial: Intensive treatment of hypertension to a SBP <120?mm?Hg in patients aged 75 and over reduces mortality and cardiovascular events Intensive treatment of hypertension to a SBP | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword (...) Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Intensive treatment of hypertension to a SBP Article Text Therapeutics/Prevention Randomised controlled trial Intensive treatment of hypertension to a SBP <120 mm Hg in patients aged 75 and over reduces mortality and cardiovascular events Michael A Weber Statistics from Altmetric.com Commentary

Evidence-Based Medicine (Requires free registration)2017